TRINESE HARDY: Open Payments
NPI 1184683872 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,493 in 129 payments from 13 companies in 2025. Trend: 2023 $1,181 · 2024 $10,765 · 2025 $17,493
Speaker / faculty: $12,121Food & beverage: $3,331Travel & lodging: $2,042
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $8,680 |
| ABBVIE INC. | 39 | $6,490 |
| Otsuka America Pharmaceutical, Inc. | 15 | $459 |
| Janssen Pharmaceuticals, Inc | 15 | $435 |
| E.R. Squibb & Sons, L.L.C. | 12 | $382 |
| Vanda Pharmaceuticals Inc. | 8 | $373 |
| Supernus Pharmaceuticals, Inc. | 11 | $175 |
| Alkermes, Inc. | 3 | $156 |
| Luye Pharma (USA) Ltd. | 1 | $125 |
| Axsome Therapeutics, Inc. | 5 | $87 |
Products named: UZEDY, VRAYLAR, INVEGA SUSTENNA, COBENFY, FANAPT, REXULTI, ABILIFY MAINTENA, Qelbree.
Industry payments across FL — which companies pay providers there.
